Allelic Subtypic Determinants of Hepatitis B Surface Antigen (i and T) That Are Distinct from D/y or W/r
Overview
Affiliations
A monoclonal antibody (I-18) was raised against an enneapeptide representing amino acids 125 to 133 of the product of the S gene of hepatitis B virus DNA [S(125-133) segment] with a sequence of Thr-Ile-126-Pro-Ala-Gln-Gly-Thr-Ser-Met. Another monoclonal antibody (T-7) was raised against an S(125-133) segment in which Ile-126 was replaced by Thr-126. In a panel of 16 samples of hepatitis B surface antigen (HBsAg) with known S gene sequences, I-18 reacted with 5 with Ile-126. T-7 reacted with 10 HBsAg samples with Thr-126; it did not, however, react with the remaining one of subtype ayw with Thr-126 flanked by Met-125 and Thr-127. The two allelic subtypic determinants, specified by Ile-126 and Thr-126 and distinct from d/y or w/r, were named i and t after isoleucine and threonine, which regulate them. They were expressed in a mutually exclusive fashion in 216 (83%) of 260 HBsAg samples from asymptomatic carriers. They were not detected in 36 (14%) samples; the failure to detect an i or t determinant was particularly common in HBsAg samples of subtype ayw (26 [79%] of 33). A part of the S gene sequence was determined for eight HBsAg samples without a detectable i or t determinant. They had an Ile-126 or Thr-126 residue that was flanked by Thr-127, not the Pro-127 commonly possessed by HBsAg samples displaying an i or t determinant. Expression of the i/t allele, therefore, would require Pro-127. In eight (3%) of the samples, both i and t determinants were detected; the presence of i and t on the selfsame HBsAg particles was verified by sandwiching the particles between I-18 and T-7. A point mutation from thymine to cytosine at nucleotide 377 in the S gene, contributing different second letters to codon 126 (ATT for Ile and ACT for Thr), would have been responsible for the assembly of HBsAg particles with both i and t determinants by means of phenotypic mixing.
The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".
Ponde R Eur J Clin Microbiol Infect Dis. 2011; 30(11):1325-40.
PMID: 21484253 DOI: 10.1007/s10096-011-1240-z.
Kim J, Jung Y, Joo M, Kim J, Yim H, Park J J Korean Med Sci. 2010; 25(2):257-64.
PMID: 20119580 PMC: 2811294. DOI: 10.3346/jkms.2010.25.2.257.
Molecular, immunological and clinical properties of mutated hepatitis B viruses.
Kreutz C J Cell Mol Med. 2002; 6(1):113-43.
PMID: 12003675 PMC: 6740305. DOI: 10.1111/j.1582-4934.2002.tb00317.x.
Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S J Virol. 1994; 68(4):2671-6.
PMID: 8139044 PMC: 236744. DOI: 10.1128/JVI.68.4.2671-2676.1994.